-
Mashup Score: 3
The Francis Crick Institute is partnering to develop novel applications for Broken String’s DNA break-mapping platform, INDUCE-seq, to investigate the impact of genomic instability in amyotrophic lateral sclerosis (ALS).
Source: www.insideprecisionmedicine.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 5Verve Starts Second Human Cardiovascular Gene Therapy Trial - 7 day(s) ago
Verve Therapeutics starts Phase I trial of its second base editing candidate therapy designed to target the PCSK9 gene.
Source: www.insideprecisionmedicine.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 6
A noninvasive, multitarget stool RNA test called ColoSense has been approved by the FDA to test for colorectal cancer.
Source: www.insideprecisionmedicine.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 5Patient Adverse Events Prevalent in Outpatient Settings - 11 day(s) ago
A study by researchers has revealed that patient adverse events are prevalent and persistent in outpatient settings.
Source: www.insideprecisionmedicine.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 94
In a first-ever human clinical trial, an mRNA cancer vaccine quickly reprograms the immune system to attack glioblastoma.
Source: www.insideprecisionmedicine.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 11
Enhertu (AstraZeneca and Daiichi Sankyo’s trastuzumab deruxtecan) has been FDA approved for all HER2 positive solid tumors.
Source: www.insideprecisionmedicine.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 3Merck Inks $1B Synthetic Biology Deal with Pearl - 2 month(s) ago
Pearl Bio has entered a $1B collaboration with Merck to discover biologic therapies comprising non-standard amino acids for drug discovery.
Source: www.insideprecisionmedicine.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 3
A large language model using generative AI could help translate patient discharge summaries and make them more understandable.
Source: www.insideprecisionmedicine.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 2Novo Gets New Approval for Wegovy and Shares Promising Early Weight Loss Pill Results - 2 month(s) ago
The FDA has approved Novo Nordisk’s Wegovy (semaglutide) for obesity with heart disease. And the company released promising early trial results for its experimental weight loss pill, amycretin.
Source: www.insideprecisionmedicine.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 6
Researchers studying mouse models of Alzheimer’s disease (AD) have found the earliest biomarker of the disease to date.
Source: www.insideprecisionmedicine.comCategories: General Medicine News, Future of MedicineTweet
RT @Inside_PM: . @TheCrick Institute and @BrokenStringBio Partner for #ALS Cell and #GeneTherapy. Find out more: https://t.co/O5MUrEHjWw ht…